 |
 |
| Meridian Offers Experienced Program Advisory Services |
|
Plan Case 3. Successfully Completing A High-Risk Merger
The industry's largest biotechnology company purchased a competitor for 20 times the competitor's prior year revenue, justifying the premium by citing the intellectual property they would gain from the acquired company. Their reasoning was correct; the acquired company is a world-leader in a high value niche in the biotech landscape. Meridian was engaged to protect the ‘value run-off' that results when intellectual property is driven away by bad merger processes. Using both our RQ tool and an extensive set of organizational diagnostics, we measured the ‘value at risk' across the acquired organization and designed and deployed an organizational integration program that accelerated the integration of the acquired company. Once successfully closed, a leading biotech analyst declared that this merger "might well provide the template for realignment in biotech."
|
